- Roche's tecentriq combination approved by FDA for adjuvant treatment of a specific type of stage iii colon cancer
The FDA approved a Tecentriq combination therapy for patients with a specific type of stage III colon cancer.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.